Invention Grant
- Patent Title: Inhibitors of indoleamine 2,3-dioxygenase (IDO)
-
Application No.: US14776035Application Date: 2014-03-12
-
Publication No.: US09675571B2Publication Date: 2017-06-13
- Inventor: James Aaron Balog , Audris Huang , Bin Chen , Libing Chen , Steven P. Seitz , Amy C. Hart , Jay A. Markwalder
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Elliott Korsen; Maureen S. Gibbons; Serena Farquharson-Torres
- International Application: PCT/US2014/023948 WO 20140312
- International Announcement: WO2014/150677 WO 20140925
- Main IPC: A61K31/135
- IPC: A61K31/135 ; A61K31/196 ; C07C255/44 ; C07C255/57 ; C07D213/84 ; C07C275/42 ; C07D317/66 ; C07C311/51 ; C07D239/42 ; C07D241/42 ; C07D257/04 ; C07D261/08 ; C07C233/55 ; C07D261/14 ; C07C235/38 ; C07D271/12 ; C07D213/56 ; A61K31/18 ; A61K31/216 ; A61K31/27 ; A61K31/36 ; A61K31/41 ; A61K31/42 ; A61K31/4245 ; A61K31/44 ; A61K31/498 ; A61K31/505 ; A61K45/06 ; A61N5/10 ; C07C69/743 ; C07C271/28 ; C07C311/47 ; C07D213/75
Abstract:
There are disclosed compounds that modulate or inhibit the enzymatic activity of indoleamine 2,3-dioxygenase (IDO), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders, such as cancer, viral infections and/or inflammatory disorders utilizing the compounds of the invention.
Public/Granted literature
- US20160022619A1 INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE (IDO) Public/Granted day:2016-01-28
Information query
